RESUMO
Introduction: Congenital Heart Disease (CHD) is the most common congenital disorder and a leading cause of infant mortality. Despite improved survival rates, patients with CHD often face malnutrition due to increased metabolic demands, feeding difficulties, and gastrointestinal dysfunction. Malnutrition in CHD is linked to poor short and long-term clinical outcomes. Gastrostomy (GT) is frequently used for long-term enteral support, and laparoscopic GT (LGT) has demonstrated advantages in children without CHD. This study evaluated a modified Georgeson's percutaneous LGT technique and its perioperative complications in children with CHD. Methods: We performed an analytical retrospective cohort study from 2018 to 2022, including patients younger than 24 months with a diagnosis of CHD who underwent LGT. The primary outcome evaluated was the presence of complications during surgery and the first thirty postoperative days. Complications were graded using Clavien-Dindo's (CD) classification. Sociodemographic, clinical, and procedure-related variables were collected. A bivariate analysis was performed using STATA 15, and a p < 0.05 was considered statistically significant. Results: Seventy-eight patients were eligible (male 56.41%, Median age 129.5 days, weight: 4.83â kg). The median surgery time was 35â min. The complication rate was 24.36%. The most frequent complications were GT site infection (10.26%), followed by leakage (8.97%) and granuloma formation (6.41%). Conversion to open surgery was significantly associated with postoperative complications (p = 0.002). Conclusion: This modified technique is well-tolerated in children with CHD, demonstrating a low rate of CD grade 3A/3B complications and no grade 4 or 5 complications.
RESUMO
El síndrome metabólico en pediatría identifica a un grupo de niños con alto riesgo de presentar eventos cardiocerebrovascular y de diabetes tipo 2 a partir de los seis años de edad. La detección temprana y tratamiento óptimo constituyen el pilar fundamental para disminuir la morbimortalidad cardiovascular a mediano y largo plazo. Esta terapéutica creará hábitos saludables familiares y promoverá el control de los factores de riesgo como alteraciones metabólicas, hipertensión arterial y obesidad en cada integrante independiente de su edad. El presente artículo muestra un abordaje práctico en el ámbito clínico de los pacientes pediátricos a partir de los seis años...
The metabolic syndrome in pediatrics identify a high risk population for cardiocerebrovascular events and type 2 diabetes since six years old. Early detection and treatment of risk factors constitute the main point of intervention to decrease the morbidity and mortality related with cardiovascular disease in the medium and long terms. This treatment will create healthy family habits and it will promote the control of these risk factors in each family member. This article presents a practical approach on this issue in pediatric clinical care since six years of age...
